HA15 inhibits binding immunoglobulin protein and enhances the efficacy of radiation therapy in esophageal squamous cell carcinoma

被引:3
|
作者
Luo, Hui [1 ]
Wang, Liuxiang [2 ]
Zhang, Deju [3 ]
Sun, Yanan [1 ]
Wang, Shujuan [1 ]
Song, Shuai [1 ]
Ge, Hong [1 ,4 ]
机构
[1] Zhengzhou Univ, Affiliated Canc Hosp, Dept Radiat Oncol, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Acad Med Sci, Zhengzhou, Peoples R China
[3] Univ Hong Kong, Sch Biol Sci, Food & Nutr Sci, Hong Kong, Peoples R China
[4] Zhengzhou Univ, Affiliated Canc Hosp, Dept Radiat Oncol, 127 Dongming Rd, Zhengzhou 450008, Henan, Peoples R China
基金
中国国家自然科学基金;
关键词
binding immunoglobulin protein; endoplasmic reticulum stress; esophageal squamous cell carcinoma; immunogenic cell death; radiation therapy; ENDOPLASMIC-RETICULUM STRESS; LUNG-CANCER; DEATH; SENSITIVITY; COMPLEMENT; AUTOPHAGY;
D O I
10.1111/cas.15712
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Proteomic profiling is a promising approach to identify novel predictors of radiation response. The present study aimed to identify potential biomarkers of radiation response by serum proteomics in esophageal squamous cell carcinoma (ESCC) patients and find efficacious therapeutic drugs to enhance the efficacy of radiation therapy (RT). Serum binding immunoglobulin protein (BIP) was identified and validated as a treatment response predictor in ESCC patients treated with RT. Novel BIP inhibitor HA15 showed antitumor activity in ESCC cells by viability assay. Tumor cell colony formation and apoptosis assay revealed targeting BIP was associated with significant improvements of radiation sensitivity. Further analyses revealed that HA15 enhanced radiation-induced endoplasmic reticulum (ER) stress and immunogenic cell death (ICD) in ESCC. Clinical data indicated that high expression of BIP was associated with poor survival in patients of ESCC. In conclusion, proteomics analysis suggested BIP was a promising predictor of radiation response in locally advanced ESCC. The BIP inhibitor HA15 acted as an ER stress inducer and ICD stimulator; RT combined with HA15 was effective in suppressing the growth of ESCC in vitro and in vivo. Pretreatment BIP was an essential prognostic biomarker in locally advanced ESCC patients treated with RT.
引用
收藏
页码:1697 / 1709
页数:13
相关论文
共 50 条
  • [1] HA15 inhibits binding immunoglobulin protein and enhances the efficacy of radiation therapy in esophageal squamous cell carcinoma (vol 114, pg 1697, 2023)
    Luo, H.
    Wang, L.
    Zhang, D.
    Sun, Y.
    Wang, S.
    Song, S.
    Ge, H.
    CANCER SCIENCE, 2023, 114 (10) : 4125 - 4126
  • [2] Targeting valosin-containing protein enhances the efficacy of radiation therapy in esophageal squamous cell carcinoma
    Luo, Hui
    Song, Hengli
    Mao, Ronghu
    Gao, Qiang
    Feng, Zhuo
    Wang, Nan
    Song, Shuai
    Jiao, Ruidi
    Ni, Peizan
    Ge, Hong
    CANCER SCIENCE, 2019, 110 (11) : 3464 - 3475
  • [3] Aspirin inhibits the carcinogenesis of esophageal squamous cell carcinoma and enhances its responses to cisplatin
    Zou, Zhigeng
    Fan, Hongjun
    Yu, Xiying
    Zhang, Shuming
    Guo, Liping
    Jiang, Wei
    Lu, Shih-Hsin
    CANCER RESEARCH, 2017, 77
  • [4] The effect of stress on efficacy of dendritic cell therapy for esophageal squamous cell carcinoma
    Akutsu, Yasunori
    Qin, Wei
    Murakami, Kentaro
    Hoshino, Isamu
    Hanari, Naoyuki
    Nishimori, Takanori
    Mori, Mikito
    Isozaki, Yuka
    Toyozumi, Takeshi
    Hu, Xin
    Suito, Hiroshi
    Akanuma, Naoki
    Takahashi, Masahiko
    Matsubara, Hisahiro
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [5] Effect of Endostar Combined With Radiation Therapy for Esophageal Squamous Cell Carcinoma on Blood Perfusion and Early Efficacy
    Jiang, Y.
    Xu, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E217 - E217
  • [6] Safety and efficacy of conversion therapy for esophageal squamous cell carcinoma.
    Tsuji, Takayuki
    Kawakubo, Hirofumi
    Takeuchi, Masashi
    Matsuda, Satoru
    Fukuda, Kazumasa
    Nakamura, Rieko
    Kitagawa, Yuko
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 362 - 362
  • [7] The efficacy and safety of FOLFOX therapy for advanced esophageal squamous cell carcinoma
    Shiraishi, Kazuhiro
    Okada, Mao
    Yamamoto, Shun
    Matsubara, Yuki
    Masuishi, Toshiki
    Shimozaki, Keitaro
    Yamamoto, Yoshiyuki
    Hirose, Suguru
    Sugiyama, Keiji
    Furuta, Mitsuhiro
    Machida, Nozomu
    Takahashi, Naoki
    Yoshii, Takako
    Kito, Yosuke
    Tsuzuki, Takao
    Boku, Shogen
    Tsuchihashi, Kenji
    Sugaya, Akinori
    Takayama, Toshizo
    Komori, Azusa
    Mitani, Seiichiro
    Matsumoto, Toshihiko
    Nishimura, Takashi
    Hirata, Kenro
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [8] Retinoblastoma 94 Enhances Radiation Treatment of Esophageal Squamous Cell Carcinoma in Vitro and in Vivo
    Zhang, Heng
    Li, Jin
    Wang, Yue-ying
    Meng, Ai-min
    Liu, Qiang
    Wang, Lei
    Chen, Feng-hua
    Wang, Xiao-chun
    Zhai, Zhi-bin
    Fu, Yue
    Wang, Qin
    JOURNAL OF RADIATION RESEARCH, 2012, 53 (01) : 117 - 124
  • [9] Metformin inhibits the radiation-induced invasive phenotype of esophageal squamous cell carcinoma
    Nakayama, Akira
    Ninomiya, Itasu
    Harada, Shinichi
    Tsukada, Tomoya
    Okamoto, Koichi
    Nakanuma, Shinichi
    Sakai, Seisho
    Makino, Isamu
    Kinoshita, Jun
    Hayashi, Hironori
    Oyama, Katsunobu
    Miyashita, Tomoharu
    Tajima, Hidehiro
    Takamura, Hiroyuki
    Fushida, Sachio
    Ohta, Tetsuo
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (05) : 1890 - 1898
  • [10] MicroRNA-1 inhibits tumorigenicity of esophageal squamous cell carcinoma and enhances sensitivity to gefitinib
    Yu, Qianqian
    Liu, Yiqian
    Wen, Chengcai
    Zhao, Yongzhao
    Jin, Shidai
    Hu, Youfang
    Wang, Feng
    Chen, Liang
    Zhang, Bin
    Wang, Wei
    Zhu, Quan
    Guo, Renhua
    ONCOLOGY LETTERS, 2018, 15 (01) : 963 - 971